Design, Drug Likeness and Molecular Docking of Novel Molecules for Anti-Tubercular Activity

被引:0
|
作者
Kumar, Lalit [1 ]
Verma, Ruchi [2 ]
机构
[1] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut, Udupi 576104, Karnataka, India
[2] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut Chem, Udupi 576104, Karnataka, India
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2018年 / 37卷 / 04期
关键词
complex; docking; flavonoid; molecular modelling; structure based drug design; ACID BIOSYNTHESIS; ACCURATE DOCKING; INHIBITORS; GLIDE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present research work we have tried to design some flavones analogues using molecular modelling Schrodinger software by structure based drug design approach which could prove to be potent for the treatment tuberculosis. For docking purpose, structure of 4RLT was retrieved from the Protein Data Bank, prepared and docked with designed flavones using Schrodinger software. The protein contained co-crystallized ligand 3,7,3', 4' tetrahydroxyflavone and all the novel molecules were docked at that particular site only to compare the interaction between ligand and residue. About ten flavone molecules were docked against beta-hydroxyacyl-ACP dehydratase HadAB complex and also their ADME properties for dug likeness were predicted using Quik prop tool of Schrodinger software. Seven flavones out of ten showed the best binding affinity, protein residue interaction with good docking score which was comparable to the originally bounded flavone molecule (Fisetin). As per the results obtained it is evident that these molecules can be considered as good candidate for further synthesis and evaluation.
引用
收藏
页码:759 / 767
页数:9
相关论文
共 50 条
  • [41] Evaluation of anti-tubercular activity of nicotinic and isoniazid analogues
    Lourenco, Maria C. S.
    Souza, Marcus V. N. de
    Pinheiro, Alessandra C.
    Ferreira, Marcelle de L.
    Goncalves, Raoni S. B.
    Nogueira, Thais Cristina M.
    Peralta, Monica A.
    ARKIVOC, 2007, : 181 - 191
  • [42] SOME NOVEL ORGANOSILANES AS POTENT ANTI-TUBERCULAR AGENTS
    SRIVASTAVA, VK
    KUMAR, P
    AGARWAL, JC
    VRAT, S
    DHAWAN, KN
    SHANKER, K
    PHARMAZIE, 1981, 36 (06): : 441 - 441
  • [43] Anti-tubercular Activity of Ruthenium (II) Complexes with Polypyridines
    Hadda, Taibi Ben
    Akkurt, Mehmet
    Baba, Mohamed Filali
    Daoudi, Maria
    Bennani, Brahim
    Kerbal, Abdelali
    Chohan, Zahid H.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (02) : 457 - 463
  • [44] Cytochrome bd oxidase: an emerging anti-tubercular drug target
    Saha, Pallavi
    Das, Samarpita
    Indurthi, Harish K.
    Kumar, Rohit
    Roy, Arnab
    Kalia, Nitin Pal
    Sharma, Deepak K.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (03): : 769 - 787
  • [45] Pharmacophore, QSAR, molecular docking, molecular dynamics and ADMET study of trisubstituted benzimidazole derivatives as potent anti-tubercular agents
    Moulishankar, Anguraj
    Sundarrajan, T.
    CHEMICAL PHYSICS IMPACT, 2024, 8
  • [46] Lipopolysaccharide Polyelectrolyte Complex for Oral Delivery of an Anti-tubercular Drug
    Sumaila, Mumuni
    Ramburrun, Poornima
    Kumar, Pradeep
    Choonara, Yahya E.
    Pillay, Viness
    AAPS PHARMSCITECH, 2019, 20 (03)
  • [47] A new, broad-spectrum anti-tubercular drug on the horizon
    Sharma, P
    CURRENT SCIENCE, 2000, 79 (04): : 400 - 401
  • [48] Unveiling the Anti-tubercular Properties of Biscoumarins, through Biological Evaluation and Docking Studies
    Acharya, Poornima
    Ramana, M. M., V
    Upadhyay, Manish
    Pavale, Ganesh
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (01) : 57 - 66
  • [49] Discovery of oxazole-dehydrozingerone based hybrid molecules as potential anti-tubercular agents and their docking for Mtb DNA gyrase
    Shinde, Suraj R.
    Inamdar, Shaukatali N.
    Obakachi, Vincent A.
    Shinde, Mahadev
    Kajee, Afsana
    Ghai, Meenu
    Karpoormath, Rajshekhar
    RESULTS IN CHEMISTRY, 2022, 4
  • [50] SYNTHESIS AND ANTI-TUBERCULAR ACTIVITY OF NOVEL PYRAZOL-5(H)-ONE DERIVATIVES
    Raval, Jignesh P.
    Patel, Purvesh R.
    Gandhi, Ankur N.
    Shah, Arpita B.
    Patel, Pradip S.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S73 - S73